PDTM-07. SYSTEMATIC DRUG IDENTIFIES DIGOXIN AS A DRUG THAT PROLONGS SURVIVAL IN PDOX MODELS OF GROUPS 3 AND 4 MEDULLOBLASTOMA AT CLINICALLY RELEVANT DOSES | Zendy

AI Assistant Blog Pricing

PDTM-07. SYSTEMATIC DRUG IDENTIFIES DIGOXIN AS A DRUG THAT PROLONGS SURVIVAL IN PDOX MODELS OF GROUPS 3 AND 4 MEDULLOBLASTOMA AT CLINICALLY RELEVANT DOSES

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.